Histologic distribution of borderline ovarian tumors worldwide: A systematic review

Journal of Gynecologic Oncology

Volumn 24, Issue 1, 2012, Pages 44-51

  Song, Taejong ^a   Lee, Yoo Young ^b   Choi, Chel Hun ^b   Kim, Tae Joong ^b   Lee, Jeong Won ^b   Bae, Duk Soo ^b   Kim, Byoung Gie ^b  

^a CHA University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Borderline ovarian tumor; Histology; Low malignant potential; Systematic review

Indexed keywords

ARTICLE; BORDERLINE OVARIAN TUMOR; DATA BASE; DATA EXTRACTION; DATA SYNTHESIS; EUROPE; FEMALE GENITAL TRACT TUMOR; HISTOPATHOLOGY; HUMAN; MIDDLE EAST; NORTH AMERICA; OVARY TUMOR; SYSTEMATIC REVIEW;

EID: 84873020411     PISSN: 20050380     EISSN: 20050399     Source Type: Journal    
DOI: 10.3802/jgo.2013.24.1.44     Document Type: Article

References (61)

1. Taylor HC Jr. Malignant and semimalignant tumors of the ovary. Surg Gynecol Obstet 1929;48:204-30.
2. Cadron I, Leunen K, Van Gorp T, Amant F, Neven P, Vergote I. Management of borderline ovarian neoplasms. J Clin Oncol 2007;25:2928-37.
3. Koskas M, Uzan C, Gouy S, Pautier P, Lhomme C, Haie-Meder C, et al. Fertility determinants after conservative surgery for mucinous borderline tumours of the ovary (excluding peritoneal pseudomyxoma). Hum Reprod 2011;26:808-14.
4. Uzan C, Kane A, Rey A, Gouy S, Duvillard P, Morice P. Outcomes after conservative treatment of advanced-stage serous borderline tumors of the ovary. Ann Oncol 2010;21:55-60.
5. Silverberg SG, Bell DA, Kurman RJ, Seidman JD, Prat J, Ronnett BM, et al. Borderline ovarian tumors: key points and workshop summary. Hum Pathol 2004;35:910-7.
6. Shih KK, Zhou Q, Huh J, Morgan JC, Iasonos A, Aghajanian C, et al. Risk factors for recurrence of ovarian borderline tumors. Gynecol Oncol 2011;120:480-4.
7. Camatte S, Morice P, Thoury A, Fourchotte V, Pautier P, Lhomme C, et al. Impact of surgical staging in patients with macroscopic "stage I" ovarian borderline tumours: analysis of a continuous series of 101 cases. Eur J Cancer 2004;40:1842-9.
8. Romagnolo C, Gadducci A, Sartori E, Zola P, Maggino T. Management of borderline ovarian tumors: results of an Italian multicenter study. Gynecol Oncol 2006;101:255-60.
9. Park JY, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH. Surgical management of borderline ovarian tumors: The role of fertility-sparing surgery. Gynecol Oncol 2009;113:75-82.
10. Kokawa K, Mikami Y, Sakata H, Oki N, Tanakas T, Yamazaki M, et al. Clinical outcome and prognostic factors in borderline tumors of the ovary: results from 17 years' experience in the Kinki District of Japan (1990-2006). Eur J Gynaecol Oncol 2009;30:155-61.
11. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151:264-9, W64.
12. Huusom LD, Frederiksen K, Hogdall EV, Glud E, Christensen L, Hogdall CK, et al. Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish casecontrol study. Cancer Causes Control 2006;17:821-9.
13. Jordan SJ, Whiteman DC, Purdie DM, Green AC, Webb PM. Does smoking increase risk of ovarian cancer? A systematic review. Gynecol Oncol 2006;103:1122-9.
14. Benito V, Lubrano A, Arencibia O, Medina N, Alvarez Eva E, Andujar M, et al. Serous and mucinous borderline ovarian tumors: are there real differences between these two entities? Eur J Obstet Gynecol Reprod Biol 2010;153:188-92.
15. Jha P, Ranson MK, Nguyen SN, Yach D. Estimates of global and regional smoking prevalence in 1995, by age and sex. Am J Public Health 2002;92:1002-6.
16. Koskas M, Uzan C, Gouy S, Pautier P, Lhomme C, Haie-Meder C, et al. Prognostic factors of a large retrospective series of mucinous borderline tumors of the ovary (excluding peritoneal pseudomyxoma). Ann Surg Oncol 2011;18:40-8.
17. Anfinan N, Sait K, Ghatage P, Nation J, Chu P. Ten years experience in the management of borderline ovarian tumors at Tom Baker Cancer Centre. Arch Gynecol Obstet 2011;284:731-5.
18. Rice LW, Lage JM, Berkowitz RS, Goodman A, Muto MG, Knapp RC, et al. Preoperative serum CA-125 levels in borderline tumors of the ovary. Gynecol Oncol 1992;46:226-9.
19. Morris RT, Gershenson DM, Silva EG, Follen M, Morris M, Wharton JT. Outcome and reproductive function after conservative surgery for borderline ovarian tumors. Obstet Gynecol 2000;95:541-7.
20. Rettenmaier MA, Lopez K, Abaid LN, Brown JV 3rd, Micha JP, Goldstein BH. Borderline ovarian tumors and extended patient follow-up: an individual institution's experience. J Surg Oncol 2010;101:18-21.
21. Vine MF, Ness RB, Calingaert B, Schildkraut JM, Berchuck A. Types and duration of symptoms prior to diagnosis of invasive or borderline ovarian tumor. Gynecol Oncol 2001;83:466-71.
22. Rao GG, Skinner EN, Gehrig PA, Duska LR, Miller DS, Schorge JO. Fertility-sparing surgery for ovarian low malignant potential tumors. Gynecol Oncol 2005;98:263-6.
23. Mink PJ, Sherman ME, Devesa SS. Incidence patterns of invasive and borderline ovarian tumors among white women and black women in the United States: results from the SEER Program, 1978-1998. Cancer 2002;95:2380-9.
24. Odegaard E, Staff AC, Langebrekke A, Engh V, Onsrud M. Surgery of borderline tumors of the ovary: retrospective comparison of short-term outcome after laparoscopy or laparotomy. Acta Obstet Gynecol Scand 2007;86:620-6.
25. Riman T, Dickman PW, Nilsson S, Correia N, Nordlinder H, Magnusson CM, et al. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study. Gynecol Oncol 2001;83:575-85.
26. Akeson M, Zetterqvist BM, Dahllof K, Jakobsen AM, Brannstrom M, Horvath G. Population-based cohort followup study of all patients operated for borderline ovarian tumor in western Sweden during an 11-year period. Int J Gynecol Cancer 2008;18:453-9.
27. Kumpulainen S, Kuoppala T, Leminen A, Komulainen M, Puistola U, Sankila R, et al. Surgical staging, treatment, and follow-up of borderline tumors in different hospital categories: a prospective nationwide survey in Finland. Acta Obstet Gynecol Scand 2007;86:610-4.
28. Hannibal CG, Huusom LD, Kjaerbye-Thygesen A, Tabor A, Kjaer SK. Trends in incidence of borderline ovarian tumors in Denmark 1978-2006. Acta Obstet Gynecol Scand 2011;90:305-12.
29. Engelen MJ, de Bruijn HW, Hollema H, ten Hoor KA, Willemse PH, Aalders JG, et al. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors. Gynecol Oncol 2000;78:16-20.
30. Kolwijck E, Thomas CM, Bulten J, Massuger LF. Preoperative CA-125 levels in 123 patients with borderline ovarian tumors: a retrospective analysis and review of the literature. Int J Gynecol Cancer 2009;19:1335-8.
31. Verbruggen MB, van Diest PJ, Baak JP, Broeckaert MA, Kenemans P, Verheijen RH. The prognostic and clinical value of morphometry and DNA cytometry in borderline ovarian tumors: a prospective study. Int J Gynecol Pathol 2009;28:35-40.
32. Donnez J, Munschke A, Berliere M, Pirard C, Jadoul P, Smets M, et al. Safety of conservative management and fertility outcome in women with borderline tumors of the ovary. Fertil Steril 2003;79:1216-21.
33. Fotopoulou C, Schumacher G, Schefold JC, Denkert C, Lichtenegger W, Sehouli J. Systematic evaluation of the intraoperative tumor pattern in patients with borderline tumor of the ovary. Int J Gynecol Cancer 2009;19:1550-5.
34. Ivanov S. Borderline ovarian tumors. Akush Ginekol (Sofiia) 2002;42:23-5.
35. Makarewicz H, Emerich J, Olszewski J. Comparison of two groups of patients with serous and mucinous types of borderline ovarian tumors. Ginekol Pol 2003;74:24-31.
36. Bouchardy C, Fernandez S, Merglen A, Usel M, Fioretta G, Rapiti E, et al. Increased risk of second cancer among patients with ovarian borderline tumors. Gynecol Oncol 2008;109:210-4.
37. Levi F, La Vecchia C, Randimbison L, Te VC. Borderline ovarian tumours in Vaud, Switzerland: incidence, survival and second neoplasms. Br J Cancer 1999;79:4-6.
38. Fauvet R, Boccara J, Dufournet C, Poncelet C, Darai E. Laparoscopic management of borderline ovarian tumors: results of a French multicenter study. Ann Oncol 2005;16:403-10.
39. De Iaco P, Ferrero A, Rosati F, Melpignano M, Biglia N, Rolla M, et al. Behaviour of ovarian tumors of low malignant potential treated with conservative surgery. Eur J Surg Oncol 2009;35:643-8.
40. Maneo A, Vignali M, Chiari S, Colombo A, Mangioni C, Landoni F. Are borderline tumors of the ovary safely treated by laparoscopy? Gynecol Oncol 2004;94:387-92.
41. Palomba S, Zupi E, Russo T, Falbo A, Del Negro S, Manguso F, et al. Comparison of two fertility-sparing approaches for bilateral borderline ovarian tumours: a randomized controlled study. Hum Reprod 2007;22:578-85.
42. Zanetta G, Rota S, Chiari S, Bonazzi C, Bratina G, Mangioni C. Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. J Clin Oncol 2001;19:2658-64.
43. Cusido M, Balaguero L, Hernandez G, Falcon O, Rodriguez-Escudero FJ, Vargas JA, et al. Results of the national survey of borderline ovarian tumors in Spain. Gynecol Oncol 2007;104:617-22.
44. Martin Jimenez A, Miralles Pi RM, Escobedo Sanchez A, Gine Martinez L, Condom Mundo E, Balaguero Llado L. Ovarian tumors of low malignant potential (borderline): a retrospective study of 31 cases. Eur J Gynaecol Oncol 1994;15:300-4.
45. Liapis A, Bakalianou K, Iavazzo C, Salakos N, Paltoglou G, Kondi-Pafiti A. A retrospective analysis of borderline ovarian tumors in a Greek university hospital. Eur J Gynaecol Oncol 2008;29:383-5.
46. Economou A, Panagopoulos P, Koutras I, Petrakos G, Karadaglis S, Karcanis C. A retrospective study of 32 borderline ovarian tumours: the experience of a nonspecialized centre. Eur J Gynaecol Oncol 2005;26:196-8.
47. Ayhan A, Guvendag Guven ES, Guven S, Kucukali T. Recurrence and prognostic factors in borderline ovarian tumors. Gynecol Oncol 2005;98:439-45.
48. Boran N, Cil AP, Tulunay G, Ozturkoglu E, Koc S, Bulbul D, et al. Fertility and recurrence results of conservative surgery for borderline ovarian tumors. Gynecol Oncol 2005;97:845-51.
49. Kanat-Pektas M, Ozat M, Gungor T, Sahin I, Yalcin H, Ozdal B. Complete lymph node dissection: is it essential for the treatment of borderline epithelial ovarian tumors? Arch Gynecol Obstet 2011;283:879-84.
50. Pirimoglu ZM, Afsin Y, Guzelmeric K, Yilmaz M, Unal O, Turan MC. Is it necessary to do retroperitoneal evaluation in borderline epithelial ovarian tumors? Arch Gynecol Obstet 2008;277:411-4.
51. Gotlieb WH, Chetrit A, Menczer J, Hirsh-Yechezkel G, Lubin F, Friedman E, et al. Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer. Gynecol Oncol 2005;97:780-3.
52. Iscovich J, Shushan A, Schenker JG, Paltiel O. The incidence of borderline ovarian tumors in Israel: a population-based study. Cancer 1998;82:147-51.
53. Behtash N, Modares M, Abolhasani M, Ghaemmaghami F, Mousavi M, Yarandi F, et al. Borderline ovarian tumours: clinical analysis of 38 cases. J Obstet Gynaecol 2004;24:157-60.
54. Li Y, Cui H, Shen DH, Zhao Y, Wei LH, Qian HN. Clinical and pathological features of borderline ovarian tumors. Zhonghua Fu Chan Ke Za Zhi 2003;38:81-4.
55. Ren J, Lou JY, Liu H, Wang P, Zhang JW, Yang KX, et al. Clinicopathologic features of 234 cases with borderline ovarian tumors. Zhonghua Fu Chan Ke Za Zhi 2009;44:116-20.
56. Zhang Z, Hong W, Li L. The clinical features and management of borderline ovarian tumors. Zhonghua Fu Chan Ke Za Zhi 1998;33:556-9.
57. Wong HF, Low JJ, Chua Y, Busmanis I, Tay EH, Ho TH. Ovarian tumors of borderline malignancy: a review of 247 patients from 1991 to 2004. Int J Gynecol Cancer 2007;17:342-9.
58. Wu TI, Lee CL, Wu MY, Hsueh S, Huang KG, Yeh CJ, et al. Prognostic factors predicting recurrence in borderline ovarian tumors. Gynecol Oncol 2009;114:237-41.
59. Kim JH, Kim TJ, Park YG, Lee SH, Lee CW, Song MJ, et al. Clinical analysis of intra-operative frozen section proven borderline tumors of the ovary. J Gynecol Oncol 2009;20:176-80.
60. Tamakoshi K, Kikkawa F, Nakashima N, Tamakoshi A, Kawai M, Furuhashi Y, et al. Clinical behavior of borderline ovarian tumors: a study of 150 cases. J Surg Oncol 1997;64:147-52.
61. Yokoyama Y, Moriya T, Takano T, Shoji T, Takahashi O, Nakahara K, et al. Clinical outcome and risk factors for recurrence in borderline ovarian tumours. Br J Cancer 2006;94:1586-91.